Posted by AGORACOM-JC
at 6:55 AM on Thursday, September 24th, 2020
Announced the signing of a 5 year agreement with the NFL Alumni Association Academy to provide its Augmented Reality Platform for the launch of their new NFLA mobile interactive products
Agreement provides for equal program revenue sharing over the 5-year term
Partnership Kick-off for NFL Alumni Academy Activation in Canton, Ohio
ImagineAR’s technology will be featured in a docuseries about the Academy that begins production on September 28th
VANCOUVER , BC and ERIE, PA , Sept. 24, 2020 – ImagineAR Inc. (CSE: IP) (OTCQB: IPNFF) (” ImagineAR ” or “Company”) a Mobile Augmented Reality Company that enables sports teams, businesses, retailers and organizations to instantly create their own AR mobile campaigns, is proud to announce the signing of a 5 year agreement with the NFL Alumni Association Academy to provide its Augmented Reality Platform for the launch of their new NFLA mobile interactive products. This agreement provides for equal program revenue sharing over the 5-year term.
ImagineAR has partnered with the NFL Alumni Academy to launch a custom platform for NFL teams to assess and select Academy players. The NFL Alumni Academy is an unprecedented in-season training program developing “NFL Ready” players training and preparing on the campus of the Pro Football Hall-of-Fame Village in Canton, Ohio . The Academy will train the top free agent football players in preparation to sign an in-season contract with NFL teams looking to replace 500+ active roster players lost during each season due to injury. WaV Sports & Entertainment manages, operates and markets the NFL Alumni Academy for the NFL Alumni Association and will implement the ImagineAR platform for the Academy. WaV expects to utilize the platform for training and motivation of its players and entertainment of fans of the NFL Alumni Academy. ImagineAR’s technology will be featured in a docuseries about the Academy that begins production on September 28 th .
Dean Dalton , NFL Alumni Association International Director of Special Events, and former NFL Minnesota Vikings Coach added “ImagineAR is providing the industry leading mobile augmented reality mobile platform to the NFL Alumni Academy to engage and activate players, coaches and sponsors to connect with football fans around the globe. ImagineAR is an elite technology that we look to utilize in a variety of ways to connect football fans from around the globe to their favorite professional athletes, coaches and celebrities. We are excited about this long term relationship with ImagineAR and the endless possibilities working together.”
ImagineAR CEO Paul Silverrstieen added: “We are honored to be selected as the Augmented Reality Platform Solution for the NFL Alumni Academy for five years. It is personally rewarding to develop AR programs to help players who have dedicated their entire lives to the sport and made every Sunday memorable for football fans.”
About NFL Alumni NFL Alumni was founded in 1967 and is the oldest and most recognizable national organization of retired professional athletes. NFL Alumni consists of former NFL players, coaches, executives, spouses, cheerleaders, and associate members. Part of NFL Alumni’s dual mission is “Caring for Kids”. Player alumni give back in their local communities by raising funds for youth-related charities through their 38 regional chapters. It is a tradition that has existed for more than 50 years. Alumni support typically raises more than $1.5 million dollars for worthwhile causes. The other half of NFLA’s mission, “Caring for our Own” is to serve, assist and inform its members and their families. Alumni members are offered a diverse package of wellness, business, career, and legal services to help members and their families be healthy, productive, and connected to one another. To learn more please visit: https://www.nflalumni.org/
ABOUT WaV Sports & Entertainment WaV Sports & Entertainment is a global sports marketing firm that specializes in sports property representation, brand side representation, and the management and production of unique sporting and entertainment events. WaV has deep roots across all professional sports as well all major motorsports series. WaV Sports & Entertainment has partnered with ImagineAR to expand their reach into the world of sports. Additional information on the Company can be found at www.WaVsports.com
About ImagineAR ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, (products, landmarks and more to instantly engage videos, information, advertisements, coupons,3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies. The AR Platform is available as an SDK Plug-in for existing mobile apps.
This News Release is available on the company’s CEO Verified Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
We encourage you to do your own due diligence and ask your broker if ImagineAR Inc. (cse: IP) is suitable for your particular investment portfolio*.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM-JC
at 3:32 PM on Wednesday, September 23rd, 2020
Announced that its Calgary Cannabis dispensary located at 140-104 58 Avenue SE, will be open for business effective Saturday, September 26, 2020
“The Spyder team is excited to commence operations at its second location and bring its best of class customer service and retail experience to one of Calgary’s busiest commercial hubs,” stated Dan Pelchovitz, the company’s CEO.
Company is also currently looking at several additional locations in both Alberta and Ontario where it intends to expand the Spyder Cannabis brand’s footprint
Vaughan, Ontario–(September 23, 2020) – Spyder Cannabis Inc. (TSXV: SPDR) (“Spyder” or the “Company”) and its wholly-owned associated applicants, The Green Spyder Inc. and Spyder Cannabis Subco Inc., is pleased to announce that its Calgary Cannabis dispensary located at 140-104 58 Avenue SE, will be open for business effective Saturday, September 26, 2020.
“The Spyder team is excited to commence operations at its second location and bring its best of class customer service and retail experience to one of Calgary’s busiest commercial hubs,” stated Dan Pelchovitz, the company’s CEO.
The company is also currently looking at several additional locations in both Alberta and Ontario where it intends to expand the Spyder Cannabis brand’s footprint.
About Spyder Cannabis Inc.
Spyder is a Cannabis, Vape and CBD retailer that operates in jurisdictions where the products are federally legal in both Canada and the United States. The Company, through its subsidiaries, is a retailer involved in the development of three retail business units. The first is the sale of Cannabis products, the second is the sale of Hemp CBD in the United States only, the third is the sale of smoking cessation products in Ontario.
For more information, please contact: Dan Pelchovitz 905-265-8273
Cautionary Statements
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release includes statements containing certain ‘forward-looking information” within the meaning of applicable securities laws (‘forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur.
“Our team at Kontrol has been very busy since the completion of pre-commercialization testing through the independent labs,” says Paul Ghezzi, CEO of Kontrol. “We have now moved to the commercialization phase for the Kontrol BioCloud® analyzer (“BioCloud analyzer” or “BioCloud”) which includes further lab testing to establish the lower detection limits. In addition, we are pleased to share that BioCloud is receiving interest from potential customers and distribution partners and we are selecting key suppliers for commercialization. We are in discussions with provincial and federal government entities regarding contributions to commercialization funding and potential future procurement. Our internal goal is to have BioCloud units commercially available in November 2020.”
Commercialization of BioCloud
As part of BioCloud’s commercialization plans, Kontrol will provide lower detection limits and operating specifications for the analyzer. Initial expectations, based on lab testing completed to date, is that BioCloud will be effective in small to medium space settings with 3 or more people, and therefore would be suitable for applications in many environments such as classrooms, offices, airplanes, trains, buses, long-term care facilities and hospitals.
Like all electrical products, BioCloud is required to operate with a CSA approval in Canada. The Company is in the process of seeking CSA approvals as part of commercialization. CSA is a leader in Standards Development and in Testing, Inspection and Certification around the world including Canada, the U.S., Europe and Asia. The CSA registered mark shows that a product has been independently tested and certified to meet recognized standards for safety or performance. The Company has a long history of success in achieving CSA approvals in our established continuous emissions business.
Operating Subsidiaries, Trademarks and Patents
Kontrol BioCloud Inc., which was recently incorporated, is a wholly owned subsidiary of Kontrol, and will be the primary sales and marketing entity for BioCloud. CEM Specialties Inc. (“CEMSI”), also a wholly owned operating subsidiary of Kontrol, will be the primary research, development, and integration entity for BioCloud.
Kontrol has commenced the trademark of the term Safe Space Technology and has initiated the patent registration for its intellectual property related to BioCloud.
Securing Supply Chain
Kontrol has selected a number of suppliers that will form part of BioCloud supply chain, and we will be announcing those names in the coming weeks, following the issuance of applicable purchase orders.
“While we are not making any claims about revenue at this time, we are building our global supply chain with the goal of being able to supply the market with up to 20,000 units per month,” says Gary Saunders VP of Kontrol. “We plan to have this substantially completed over the coming weeks.”
Strengthened Balance Sheet and Discussions for Additional Government Funding
As of September 22, 2020, the Company has received approximately $1 Million in cash from the exercise of common share options and warrants which has strengthened Kontrol’s balance sheet to advance BioCloud’s commercialization.
About Kontrol BioCloud
BioCloud is a real-time analyzer designed to detect airborne viruses. It has been designed to operate as a safe space technology by sampling the air quality continuously. With a proprietary detection chamber that can be replaced as needed, viruses are detected, and an alert system is created in the Cloud or over local intranet. BioCloud has been designed for spaces where individuals gather including classrooms, retirement homes, hospitals, mass transportation and others. It can be an important technology which supports the entire system of individual testing and contact tracing.
The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus).
About Kontrol Energy
Kontrol Energy Corp. (CSE:KNR) (OTCQB:KNRLF) (FSE:1K8) is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology. With a disciplined mergers and acquisition strategy, combined with organic growth, Kontrol Energy Corp. provides market-based energy solutions to our customers designed to reduce their overall cost of energy while providing a corresponding reduction in greenhouse gas (GHG) emissions.
Kontrol Energy is one of Canada’s fastest growing companies in 2018 and 2019 as ranked by Canadian Business and Maclean’s.
Additional information about Kontrol Energy Corp. can be found on its website at www.kontrolenergy.com and by reviewing its profile on SEDAR at www.sedar.com.
For further information, contact:
Paul Ghezzi, Chief Executive Officer [email protected] or [email protected] Kontrol Energy Corp., 180 Jardin Drive, Unit 9, Vaughan, ON L4K 1X8 Tel: 905.766.0400, Toll free: 1.844.566.8123
Neither IIROC nor any stock exchange or other securities regulatory authority accepts responsibility for the adequacy or accuracy of this release.
Forward-Looking Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.
Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief is based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, that sufficient capital will be available to the Company and that technology will be as effective as anticipated.
However, forward-looking statements are subject to risks, uncertainties, and other factors, which could cause actual results to differ materially from future results expressed, projected, or implied by such forward-looking statements. Such risks include, but are not limited to, that sufficient capital and financing cannot be obtained on reasonable terms, or at all, that technologies will not prove as effective as expected, that customers and potential customers will not be as accepting of the Company’s product and service offering as expected, and government and regulatory factors impacting the energy conservation industry. In particular, successful development and commercialization of the Kontrol BioCloud Analyzer are subject to the risk that the Kontrol BioCloud Analyzer may not prove to be successful in detecting the virus that causes COVID-19 effectively or at all, uncertainty of timing or availability of any regulatory approvals and Kontrol’s lack of track record in developing products for medical applications.
Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and are based on the beliefs, estimates, expectations, and opinions of management on such date. Kontrol does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required under applicable securities law. Readers are cautioned to consider these and other factors, uncertainties, and potential events carefully and not to put undue reliance on forward-looking information.
Primo has recently invested in several brands and is pursuing partnerships with retailers and distribution companies in Canada and the United States.
Primo’s management is in the process of building a corporate road map to further vertically integrate the Company, specifically by way of the “Primo” & “Thrive,” brands and a selection of curated partner brands.
Most recently Primo announced that it has received its NaturalProduct Number(NPN) and it has been issued a Medical Device Establishment License(MDEL) from Health Canada.
Posted by AGORACOM-JC
at 10:04 AM on Tuesday, September 22nd, 2020
Unveils today, at its Annual and Special Meeting of Shareholders, a strategy to become a global on-site dross processor delivering zero-landfill/reduced carbon, and further underscored how DROSRITE™ reduces greenhouse gas (GHG) emissions
Company is pleased to provide additional information with respect to this strategy as well as a general DROSRITE™ update in the following Q&A format
MONTREAL, Sept. 22, 2020 — PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch systems, unveils today, at its Annual and Special Meeting of Shareholders, a strategy to become a global on-site dross processor delivering zero-landfill/reduced carbon, and further underscored how DROSRITE™ reduces greenhouse gas (GHG) emissions.
The Company is pleased to provide additional information with respect to this strategy as well as a general DROSRITE™ update in the following Q&A format.
Q.Before we jump into theessenceof your announcement,could you onceagain, forthose that are new to theDROSRITE™story, please describe to us what DROSRITE™ is,and some of its many advantages?
A. Most certainly.
It’s simple. Let’s take an aluminum smelter as an example. As the hot aluminum is formed, it comes in contact with oxygen, and a dross is formed on the surface. This dross acts like a sponge and it effectively absorbs valuable metal. The smelter skims the dross and puts it aside to cool down. Although dross is considered a waste generated by the metallurgical industry, it contains valuable metal that the smelter would like to reclaim. Typically, the dross is sent off site to be processed by a third party who usually uses a salt-based recovery system. Salt, if it comes in contact with aluminum, could contaminate the batch and, as such, salt is usually prohibited from being on site and, ergo, the need to ship dross off-site to be processed. These third parties, who use salt, generate salt cakes, which are a hazardous by-product of their dross processing technique.
PyroGenesis’ DROSRITE™ system is a salt-free, cost-effective, sustainable process for maximizing metal recovery from dross. PyroGenesis’ patented process avoids costly loss of metal while reducing a smelter’s carbon footprint and energy consumption, thereby providing an impressive return on investment.
With metal manufacturers, such as aluminum, being subjected to increased pressure from regulatory authorities to eliminate landfilling of hazardous salt cakes from traditional recovery operations, combined with tight operating margins, PyroGenesis’ DROSRITE™ system is able to (i) increase metal recovery, without producing any hazardous by-products, while at the same time (ii) reducing operating costs.
In short, PyroGenesis’ DROSRITE™ system is a proven method of recovering valuable metal from dross that (i) is salt-free, so no hazardous by-products, (ii) can process the dross cheaper than conventional methods, and (iii) has demonstrated higher metal recovery rates. Non-hazardous, cheaper and with higher recovery rates, who could ask for more? The increased recovery rate alone could save an owner/operator over $1M/year using PyroGenesis’ 5000 tons/year DROSRITE™ system.
Our primary target is currently aluminum dross as this was the market, we first introduced the DROSRITE™ process to and, as you can imagine, it is much easier to leverage off of that success than to start marketing to a new sector.
Since announcing several years ago our intention to enter this marketplace, we have (i) sold the first system for $600K, (ii) sold the second system to the same client for $1.02MM, (iii) sold 2 systems to a subsequent client, iv) the technology was used for a 7 system order for over $20MM, (v) developed a tolling strategy, and (vi) partnered with a Japanese multi-billion dollar trading house to accelerate that very same strategy.
Now that we are inside the fence, we now have the “Golden Ticket” to additional opportunities.
Q.What do you mean by insidethe fence andmore importantlyGoldenTicketopportunities?
A. By inside the fence, we are referring to the fact that DROSRITE™ system operates on site, i.e. inside the smelter’s facility. By Golden Ticket, we mean the opportunity it is created by operating inside the fence. By operating inside the fence, we are able to witness firsthand other challenges facing the industry and to speak to operators and plant managers with respect to these issues, which provide us with an ideal situation in which we can pitch solutions. Having this Golden Ticket essentially is how we came to articulate, and execute, the strategy unveiled today. We are effectively solving a (horizontal) problem we identified inside the fence.
Q.So, the strategy unveiled today was as aresult of being inside the fence?
A. Definitely.
We are proud to say that DROSRITE™ has compelling advantages in and of its own right, as is clearly demonstrated by our recent successes. A natural byproduct of treating dross is the creation of residues which have been easily handled in the past. Of late, there has been increased pressure to find alternate methods in handling residuals other than traditional landfilling. It was PyroGenesis’ strategic decision to address this problem through (i) its expertise, (ii) exclusive joint ventures, and/or (iii) acquisitions.
If successful, the combination of treating dross and residues will create what we believe to be one of the first, if not the first, global onsite dross processor delivering a zero-landfill/reduced carbon solution. We know of no other company offering this. We would be offering, in our opinion, the ultimate green solution to this problem. It would effectively be a formattable offering, which would, in our opinion, be difficult to compete against, thereby giving us a distinctive advantage over other options.
Q. Can you explain in more detail the difference between dross and residues?
A. Most certainly.
Dross is 60% metal and 40% residue. DROSRITE™ is recovering the 60% metal and because it does not contaminate the 40% residues with salt, it presents a unique additional value-added opportunity. These residues have the capacity to be converted into chemical and metallurgical products. This would be an easy expansion of our service offering to the aluminum industry such that PyroGenesis would build, install, and operate turn-key plants that are essentially a cradle to grave and zero landfill solution. This should significantly increase revenues and operating margins at a DROSRITE™ plant.
Q. Could you give usanexample of what you mean by handling residuesother than traditional landfilling?
A. We believe we have clear visibility on creating valuable materials from these residuals which are often times landfilled. One example would be converting a particular residue into ammonium sulphate or aluminum sulphate, both high value chemical products. We effectively would be converting these landfilled products into useful commodities with obvious benefits to the environment. We have already demonstrated to the Board that this can be done economically.
Q. If I understand correctly,DROSRITE™onits own reducesgreenhouse gas emissions andinaddressing residueswould beanadditional environmental benefit?
A. Exactly.
DROSRITE™ has always reduced greenhouse gas emissions.
Let me explain.
There are two main sources of greenhouse gas reduction:
Direct: mainly due to savings in (i) transportation and (ii) by not burning fossil fuels in a Rotary Salt Furnace (RSF)
Indirect: mainly due to the increased recovery of aluminum (less emissions than producing aluminum from primary resources)
The following table 1 summarizes the potential emissions reduction assuming all the dross produced in the world 2 was treated with DROSRITE™.
Sector
Dross volume (TPY)
Direct reductions (t_eqCO2 per year)
Indirect reduction (t_eqCO2 per year)
Total (t_eqCO2 per year)
Car equivalent (US EPA)
Primary
600,000
199,800
864,000
1,063,800
231,261
Secondary
1,450,000
424,850
1,116,500
1,541,350
335,076
Downstream
950,000
316,350
1,102,000
1,418,350
308,337
TOTAL
3,000,000
941,000
3,082,500
4,023,500
874,674
Therefore, more than 4 million tonnes of greenhouse gas can be reduced each year (which is the equivalent of removing close to 875,000 cars off the road each year) if the world’s aluminum dross was treated with DROSRITE™. According to the USEPA, an average passenger car in the US emits 4.6 tonnes per year of CO 23 . This equates to removing an average of 1,458 cars/year off the road, year in and year out, for each of PyroGenesis’ 5 tonnes systems, or close to 3,000 cars/year for each of the Company’s 10 tonnes systems.
Q.How does this affect yourrelationshipwith the Japanese tradinghouse,and can you update the statuswith them?
A. That is a very interesting question because the effective implementation of our strategy will make tolling a more compelling option to both us, as a provider and to potential clients, as we become a one-stop-shop/total solution for these problems. Our relationship with the Japanese trading house envisioned developing tolling opportunities by first starting in the Americas and then leveraging off that success worldwide. We are currently redrafting our agreement to address both (i) the impact of the strategy articulated today and (ii) a genuine interest by the Japanese trading house to develop a closer relationship with respect to our DROSRITE™ offerings.
Q. When might you expect further developments with respect to the strategy announced today?
A. As I said, we have clear visibility on putting in place this strategy and expect to announce something before year-end. We are confident enough in the eventual success that we have already proposed this new offering existing clients.
We are also in the process of incorporating this new offering in existing tolling opportunities and we expect it to be a significant differentiating factor in those situations that involved competitive bidding. We are the front runners in a number of tolling opportunities as well as a number of potential outright sales. Without a doubt, COVID-19 has slowed down the business development aspect of completing new contracts as many as our potential clients are managing the ever-changing COVID-19 environment with limited staff as certain facilities slowed down production and/or expansion due to the crisis. Of note, we have seen a turnaround as worldwide aluminum production increase to pre-COVID levels.
About PyroGenesis Canada Inc.
PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com .
This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statementsreflectthecurrentviewsoftheCorporationwithrespecttofutureeventsandaresubject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com,or atwww.otcmarkets.com.Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws .
Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this pressrelease.
SOURCE PyroGenesis Canada Inc.
For further information please contact: Rodayna Kafal, Vice President Investors Relations and Strategic Business Development Phone: (514) 937-0002, E-mail: [email protected] RELATED LINK: http://www.pyrogenesis.com/
Posted by AGORACOM-JC
at 8:32 AM on Tuesday, September 22nd, 2020
Announced the successful completion of the first phase of three deliverables under a contract to support a U.S. military customer featuring the Company’s signature Tactical Awareness and Situational Control System” (“TASCS”)
First deliverable under a $500,000 (CAD) contract demonstrated the TASCS Integrated Fires Module on mortars and the Augmented Weapon Sight, a system developed by AeroVironment Inc. and KWESST to provide real-time situational awareness and targeting information
“These important military exercises demonstrate the maturity of the TASCS system,” said KWESST CEO Jeff MacLeod
Ottawa, Ontario–(September 22, 2020) – KWESST Micro Systems Inc. (TSXV: KWE) (“KWESST” or “the Company”) today announced the successful completion of the first phase of three deliverables under a contract to support a U.S. military customer featuring the Company’s signature Tactical Awareness and Situational Control System” (“TASCS”).
This first deliverable under a $500,000 (CAD) contract demonstrated the TASCS Integrated Fires Module (“IFM”) on mortars and the Augmented Weapon Sight (“AWS”), a system developed by AeroVironment Inc. (“AeroVironment”) and KWESST to provide real-time situational awareness and targeting information. AWS streams Full Motion Video (“FMV”) from an overhead Unmanned Aerial Vehicle (“UAV” or “drone”) manufactured by AeroVironment into the TASCS architecture for the purpose of target identification, accurate first-shot hits and real-time Battle Damage Assessment (“BDA”). The AWS system has been an ongoing collaboration between KWESST and AeroVironment.
“These important military exercises demonstrate the maturity of the TASCS system,” said KWESST CEO Jeff MacLeod. “We are very pleased at the performance of the system and the valuable user feedback. We expect the next two contracted demonstration exercises later this year to attract added customer attention and the development of operating procedures that will be employed in more extensive exercises expected in early 2021.”
David Luxton, Executive Chairman, added, “Demonstration exercises like this with military customers are an important phase in the process towards potential introduction into service. It is very encouraging that this key U.S. military customer is scheduling additional exercises, and that at least two other NATO military customers have similar capability demonstration contracts under consideration.”
About TASCS, IFM and AWS
“TASCS” is an app and snap-on weapon adaptor that streams situational awareness and targeting information from any source directly to soldiers’ smart devices and their weapons systems for a leap ahead in safer and more effective engagement of adversaries. “IFM” is the variant of TASCS that integrates this capability into many short-range and long-range weapons systems, including grenade launchers and mortars. “AWS” utilizes the TASCS system to stream situational and targeting information from AeroVironment Unmanned Aerial Vehicles (“UAV”s, or “drones”) directly to the TASCS display on soldiers’ smart devices and weapons systems in real time.
About KWESST
KWESST develops and commercializes high-value ultra-miniaturized technology applications that make a critical difference to the safety and operational effectiveness of personnel in the defence and security industries. The company’s current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users’ smart devices and weapons; the autonomous Grey GhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTM electronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and ATAK (Android Tactical Assault Kit) among others. KWESST also has developmental “smart ordnance” projects including its “Shot Counter” system, which records the number and type of rounds fired, for optimized firearms maintenance and performance. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE and trades on the TSXV under the symbol KWE.
This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the timing for the commencement of trading and the plans and operations of KWESST after giving effect to the Qualifying Transaction. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Posted by AGORACOM-JC
at 7:09 AM on Tuesday, September 22nd, 2020
ImagineAR CEO Alen Paul Silverrstieen will be presenting at Wall Street Reporter’s “Next Super Stock” livestream conference on September 24, 2020 at 12:30pm EDT .
VANCOUVER , BC AND ERIE, PA , Sept. 22, 2020 – Imagine AR Inc . (CSE: IP), (OTCQB: IPNFF), the ONLY Self-Service Augmented Reality Mobile Platform for sports teams and businesses to instantly create immersive campaigns around the world is excited to announce that ImagineAR CEO Alen Paul Silverrstieen will be presenting at Wall Street Reporter’s “Next Super Stock” livestream conference on September 24, 2020 at 12:30pm EDT .
For those unable to join the live event, a video of the presentation will be posted later.
About “Next Super Stock Live!” conference:
Wall Street Reporter’s “NEXT SUPER STOCK Live!” The conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead.
About ImagineAR
ImagineAR Inc. (CSE: IP) (OTC: IPNFF) is an augmented reality (AR) platform, ImagineAR.com, that enables businesses of any size to create and implement their own AR campaigns with no programming or technology experience. Every organization, from professional sports franchises to small retailers, can develop interactive AR campaigns that blend the real and digital worlds. Customers simply point their mobile device at logos, signs, buildings, (products, landmarks and more to instantly engage videos, information, advertisements, coupons, 3D holograms and any interactive content all hosted in the cloud and managed using a menu-driven portal. Integrated real-time analytics means that all customer interaction is tracked and measured in real-time. The AR Enterprise platform supports both IOS and Android mobile devices and upcoming wearable technologies. The AR Platform is available as an SDK Plug-in for existing mobile apps.
This News Release is available on the company’s CEO Verified Discussion Forum , a moderated social media platform that enables civilized discussion and Q&A between Management and Shareholders.
We encourage you to do your own due diligence and ask your broker if Imagination Park Entertainment Inc. (cse: IP) is suitable for your particular investment portfolio*.
The Canadian Securities Exchange has neither approved nor disapproved the contents of this press release. This press release may include ‘forward-looking information’ within the meaning of Canadian securities legislation, concerning the business of the Company. The forward looking information is based on certain key expectations and assumptions made by ImagineAR management. Although ImagineAR believes that the expectations and assumptions on which such forward- looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because ImagineAR can give no assurance that it will prove to be correct. These forward-looking statements are made as of the date of this press release, and ImagineAR disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
Posted by AGORACOM-JC
at 9:57 AM on Monday, September 21st, 2020
SPONSOR: Red Light Holland (CSE: TRIP) is engaged in the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands. Learn more.
Can magic mushrooms treat depression? Biotech COMPASS Pathways prices upsized US IPO above the range at $17
Raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16
The company offered 0.8 million more ADSs than anticipated
At pricing, the company raised 27% more in proceeds than expected
Contributor: Renaissance Capital
COMPASS Pathways, a British Phase 2 biotech developing a psilocybin-based therapy for depression, raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16. The company offered 0.8 million more ADSs than anticipated. At pricing, the company raised 27% more in proceeds than expected.
COMPASS Pathways plans to list on the Nasdaq under the symbol CMPS. Cowen, Evercore ISI and Berenberg acted as lead managers on the deal.
The company is focusing on using its proprietary formulation of psilocybin, COMP360, in conjunction with psychological support as a way to help individuals who have treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD. COMPASS is currently evaluating COMP360 in conjunction with psychological support in a Phase 2b trial and plans to report data from this trial in late 2021. Classified as a Schedule I drug, psilocybin is considered a serotonergic hallucinogen and is an active ingredient in some species of mushrooms.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital’s research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital’s Renaissance IPO ETF (symbol: IPO), Renaissance International ETF (symbol: IPOS), or separately managed institutional accounts may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Posted by AGORACOM-JC
at 9:32 AM on Monday, September 21st, 2020
Company has launched its new domain www.PlantX.ca to better serve the Canadian market
New .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform
VANCOUVER, BC, Sept. 21, 2020 – Vegaste Technologies Corp. (the ” Company ” or ” Vegaste “) (CSE: VEGA ), is pleased to announce that the Company has launched its new domain www.PlantX.ca to better serve the Canadian market.
The new .ca domain will allow PlantX, the one-stop-shop for everything plant-based and the digital face of the plant-based community, to strengthen its Canadian presence and ability to offer its growing plant-based product line to Canadian consumers using its e-commerce platform.
The new domain www.PlantX.ca will feature a growing list of partnerships with Canadian companies including Vita Life Fresh Market and UpMeals to offer plant-based vitamins, supplements, groceries, PlantX-branded water and plant-based meals made by LA-based chef Gregg Drusinsky . In addition to its e-commerce functionality, the site will offer Canadian consumers weekly updated plant-based recipes, restaurant resources and connects like-minded users in a community forum.
“Having a “.ca” domain is very exciting for us as a Canadian-based company,” said Sean Dollinger , PlantX founder “We plan to use this as an example of what we can do around the world as we expand, continue making new partnerships, and offer the best products and experience in every market.”
“At PlantX we’ve built our online platform with a different set of inventory, shipping logistics, payment processors, and other logistics separated by region,” says Alexandra Hoffman , PlantX Chief Marketing Officer. “Dividing the company traffic among different domains makes the company’s regional logistics systems better. I work very close with our development team, and it’s so exciting to see how quickly we can deploy sites for new locations.”
Since its inception in October, 2019, the Company’s PlantX platform has quickly emerged as an industry leader. As the fledgling plant-based sector continues its explosive growth, the Company will be at the forefront by continually evolving and delivering new ways to expand PlantX. With its forward-looking, cutting edge approach, the Company will continue to secure significant partnerships across North America while exploring innovative ways to expand both its e-commerce capabilities and digital resources to help educate, inspire, and uplift consumers.
About Vegaste
As the digital face of the plant-based community, Vegaste’s PlantX platform is the one-stop-shop for everything plant-based. With its fast growing category verticals, the Company will offer customers across North America more than 10,000 plant-based products by the end of September. In addition to offering meal and indoor plant deliveries, Vegaste currently has plans underway to expand its product lines to include cosmetics, vitamins, clothing, and its own water brand — but the business is not limited to an e-commerce platform. Vegaste uses its digital platform to build a community of like-minded consumers and most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs, and brands. Vegaste eliminates the barriers to entry for anyone interested in living a plant-based lifestyle, and thriving in a longer, healthier, and happier life.
The Company’s lynchpin www.PlantX.com is the digital face of everything plant-based and fueled by the power of education and accessibility. For those who don’t have the time to cook their own healthy plant-based meals, Vegaste offers a wide array of pre-made meals curated by Executive Chefs and nutritionists. For those looking to learn how to cook their own plant-based meals, Vegaste offers regularly updated weekly recipes. Unlike other plant-based e-commerce companies, Vegaste has a large selection of indoor plants for sale. The site educates consumers on the benefits of a plant-based diet with a specialized blog, connects like-minded individuals with its forum, and provides resources for the best plant-based restaurants, pop-up retailers and products across Canada and the USA .
Forward-Looking Information
This press release contains “forward-looking information” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. The forward-looking information contained herein includes statements regarding the business and strategic plans of the Company.
By their nature, forward-looking information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the forward-looking information in this press release including, without limitation: the Company’s ability to secure additional commercial partnerships across North America , the Company’s ability to comply with all applicable governmental regulations including all applicable food safety laws and regulations; impacts to the business and operations of the Company due to the COVID-19 epidemic; a limited operating history, the ability of the Company to access capital to meet future financing needs; the Company’s reliance on management and key personnel; competition; changes in consumer trends; foreign currency fluctuations; and general economic, market or business conditions.
Additional risk factors can also be found in the Company’s continuous disclosure documents which have been filed on SEDAR and can be accessed at www.sedar.com . Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.
The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Posted by AGORACOM-JC
at 9:27 AM on Monday, September 21st, 2020
Avicanna Rapid Act Spray
RHO Phyto™ Rapid Act Sprays are now available nationwide in high ratios of CBD to THC and are designed for rapid absorption and with lemon-mint flavour on the Medical Cannabis by Shoppers™ portal.
The Rapid Act Sprays are also available for the Medical Cannabis Real World Evidence Studies (MC-RWE) conducted by the University Health Network in partnerships with Medical Cannabis by Shoppers along side RHO Phyto’s Micro Drop Oil formulations.
TORONTO , Sept. 21, 2020 – Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that its advanced RHO Phyto Rapid Act Sprays are now officially available nationwide in Canada on the Medical Cannabis by Shoppers (” Shoppers “) portal, as well as through the Medical Cannabis Real-World Evidence Study at the University Health Network.
Avicanna’s RHO Phyto product line is now commercially available after years of research and development through collaborations with world class academic and clinical organizations. The development of RHO Phyto products has focused on the key properties in drug development that health care providers seek when recommending a medical product to their patients such as formulation stability for consistent dosing, enhanced absorption and a range of onset times.
The Rapid Act Spray is a sublingual spray and is among the second set of Avicanna’s RHO Phyto products available for purchase through Shoppers. The sublingual sprays bypass first-pass metabolism and are quickly absorbed in the mucosal lining under the tongue. The RHO Phyto Rapid Act Spray provides an alternative delivery form to the RHO Phyto Micro Drops (also available for sale through Shoppers) which are absorbed through the oral route. The RHO Phyto Rapid Act Sprays have been formulated with specific ingredients that enhance absorption and the onset time of cannabinoids across the mucous membrane beneath the tongue. The lemon-mint flavoured sprays will be available in 10:20 CBD and 2:40 (w/w) THC to CBD ratios.
Dr. Justin Grant , Avicanna’s Executive Vice President of Scientific Affairs, commented, “The RHO Phyto Rapid Act Sprays are designed for faster onset and can be used in acute conditions where patients seek faster relief. The sublingual sprays can also be used to supplement slower and longer acting products, such as the RHO Phyto Micro Drop, when occasional higher doses may be required. Sublingual administration provides an alternative to the potentially harmful effects of consuming inhalation products.”
In August 2020 , Avicanna launched its blood orange flavoured RHO Phyto Micro Drop 2:50 CBD and Micro Drop 5:20 CBD. In the coming months, Avicanna will be launching its much-anticipated RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules. To ensure batch-to-batch consistency and high-quality products, these formulations are manufactured at MediPharm Labs Inc, a Good Manufacturing Practices (” GMP “) certified facility. In addition to strict GMP manufacturing, all RHO Phyto products undergo GMP-level analytical testing by Sigma Analytical Services Inc. and use blockchain technology developed by TruTrace Technologies Inc. to manage, track and trace each step of the supply chain.
Detailed guidelines outlining dosing and titration for Health Care Practitioners (” HCPs “) and patients is available on the RHO Phyto website at www.rhophyto.com . In addition, the Avicanna Academy includes additional product information for patients, frequently asked questions, and a recording of Avicanna’s 3rd annual symposium which was hosted virtually in partnership with Shoppers on July 21, 2020. For more information visit https://www.avicanna.com/the-avicanna-academy/ .
The Company has also re-branded and re-launched its subsidiary, My Cannabis Clinic (formerly known as My Cannabis), which specializes in assisting patients to gain access to medical cannabis and cannabinoid-based products for medical use. My Cannabis Clinic is devoted to providing HCPs and patients with the support and education needed for medical cannabis use. My Cannabis Clinic believes in providing quality care to patients and providing education on the considerations and potential benefits that cannabis has to offer for medical use. Information about My Cannabis Clinic can be found at https://mycannabisclinic.org/ .
About Avicanna
Avicanna is a diversified and vertically integrated Canadian biopharmaceutical company focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments.
Avicanna is an established leader in cannabinoid research and development, which it primarily conducts at its R&D headquarters in the Johnson & Johnson Innovation Centre, JLABS @ Toronto, Canada and in collaboration with leading Canadian academic and medical institutions. In addition to its developing pharmaceutical pipeline, Avicanna’s team of experts have developed and commercialized several industry leading product lines, including:
Pura H&W™: an advanced and clinically tested line of CBD consumer derma-cosmetic products; and,
RHO Phyto™: an advanced line of medical cannabis products containing varying ratios of CBD and THC currently available nation-wide across Canada in partnership with Medical Cannabis by Shoppers™, a subsidiary of Shoppers Drug Mart. RHO Phyto is the first strictly medical formulary of advanced “Cannabis 2.0” products, containing oils, sprays, capsules, creams, and gels, all developed with scientific rigour, manufactured under GMP standards and supported by pre-clinical data.
With ongoing clinical trials on its derma-cosmetic (Pura H&W), medical cannabis (RHO Phyto) and a pipeline of pharmaceutical products, Avicanna’s dedication to researching the important role that cannabinoids play in an increasingly wider scope of products has been at the core of the Company’s vision since its inception. Furthermore, Avicanna’s commitment to education is demonstrated through its annual medical symposium, the Avicanna Academy educational platform, and the My Cannabis Clinic patient program through its subsidiary company.
Avicanna manages its own supply chain including cultivation and extraction through its two majority-owned subsidiaries, Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S., both located in Santa Marta, Colombia. Through these sustainable, economical, and industrial scale subsidiaries, Avicanna cultivates, processes, and commercializes a range of cannabis and hemp cultivars dominant in CBD, CBG, THC, and other cannabinoids for use as active pharmaceutical ingredients. Avicanna’s Avesta Genetica program specializes in the development and optimization of rare cultivars for commercial production along with feminized seeds for global export. In June 2020, Avicanna made history with a shipment of hemp seeds to the United States of America by completing the first ever export of hemp seeds from Colombia.
SOURCE Avicanna Inc.
Stay Connected
For more information about Avicanna, visit www.avicanna.com , call 1-647-243-5283, or contact Setu Purohit , President by email at [email protected] .
Cautionary Note Regarding Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws. Forward-looking information contained in this press release may be identified by the use of words such as, “may”, “would”, “could”, “will”, “likely”, “expect”, “anticipate”, “believe, “intend”, “plan”, “forecast”, “project”, “estimate”, “outlook” and other similar expressions, and includes statements with respect to the ability of the RHO Phyto Rapid Act Sprays to be used in acute conditions where patients seek faster relief, the ability of the RHO Phyto Rapid Act Sprays to be used to supplement slower and longer acting products, the ability of the Company launching the RHO Phyto Deep Tissue Gel, Daily Cream and Simple Dose Capsules , the ability of My Cannabis Clinic to provide HCPs and patients with the support and education needed for medical cannabis use, and that there is a benefit to using cannabis for medical purposes. Forward-looking information is not a guarantee of future performance and is based upon a number of estimates and assumptions of management in light of management’s experience and perception of trends, current conditions and expected developments, as well as other factors relevant in the circumstances, including assumptions in respect of current and future market conditions, the current and future regulatory environment; and the availability of licenses, approvals and permits.
Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. Forward-looking information is subject to a variety of risks and uncertainties that could cause actual events or results to differ materially from those projected in the forward-looking information. Such risks and uncertainties include, but are not limited to current and future market conditions, including the market price of the common shares of the Company, and the risk factors set out in the Company’s annual information form dated April 15, 2020 , filed with the Canadian securities regulators and available under the Company’s profile on SEDAR at www.sedar.com .
The statements in this press release are made as of the date of this release. The Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.
